Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.
Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, Vaughn NR, Baran N, Deng Q, Matthews J, Gunaratne PH, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, Abbas HA. Wang B, et al. Among authors: veletic i. Nat Commun. 2024 Feb 28;15(1):1821. doi: 10.1038/s41467-024-45916-6. Nat Commun. 2024. PMID: 38418901 Free PMC article.
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek S, Foltz L, Gupta V, Hasserjian R, Manshouri T, Mascarenhas J, Mesa R, Pozdnyakova O, Ritchie E, Veletic I, Gamel K, Hamidi H, Han L, Higgins B, Trunzer K, Uguen M, Wang D, El-Galaly TC, Todorov B, Gotlib J. Verstovsek S, et al. Among authors: veletic i. Haematologica. 2023 Oct 1;108(10):2730-2742. doi: 10.3324/haematol.2022.282411. Haematologica. 2023. PMID: 37165840 Free PMC article. Clinical Trial.
GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes.
Manshouri T, Veletic I, Li P, Yin CC, Post SM, Verstovsek S, Estrov Z. Manshouri T, et al. Among authors: veletic i. Cell Death Dis. 2022 May 20;13(5):481. doi: 10.1038/s41419-022-04932-4. Cell Death Dis. 2022. PMID: 35595725 Free PMC article.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
Rozovski U, Veletic I, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Verstovsek S, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: veletic i. J Immunol. 2022 Jun 15;208(12):2847-2855. doi: 10.4049/jimmunol.2101105. Epub 2022 May 20. J Immunol. 2022. PMID: 35595309 Free PMC article.
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells.
Rozovski U, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Veletic I, Ferrajoli A, Bose P, Thompson P, Jain N, Verstovsek S, Wierda W, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: veletic i. Oncotarget. 2021 Mar 2;12(5):401-411. doi: 10.18632/oncotarget.27884. eCollection 2021 Mar 2. Oncotarget. 2021. PMID: 33747356 Free PMC article.
Myelofibrosis osteoclasts are clonal and functionally impaired.
Veletic I, Manshouri T, Multani AS, Yin CC, Chen L, Verstovsek S, Estrov Z. Veletic I, et al. Blood. 2019 May 23;133(21):2320-2324. doi: 10.1182/blood-2018-10-878926. Epub 2019 Feb 11. Blood. 2019. PMID: 30745304 Free PMC article.
Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis.
Lucijanic M, Veletic I, Rahelic D, Pejsa V, Cicic D, Skelin M, Livun A, Tupek KM, Stoos-Veic T, Lucijanic T, Maglicic A, Kusec R. Lucijanic M, et al. Among authors: veletic i. Wien Klin Wochenschr. 2018 Feb;130(3-4):126-133. doi: 10.1007/s00508-018-1318-z. Epub 2018 Jan 25. Wien Klin Wochenschr. 2018. PMID: 29372410
13 results